Phase 1/2 Study Of The Activin Receptor-Like Kinase 2 (Alk2) Inhibitor Zilurgisertib (Incb000928, Limber-104) As Monotherapy Or With Ruxolitinib In Patients With Anemia Due To Myelofibrosis
Zilurgisertib;Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1/2 Study Of The Activin Receptor-Like Kinase 2 (Alk2) Inhibitor Zilurgisertib (Incb000928, Limber-104) As Monotherapy Or With Ruxolitinib In Patients With Anemia Due To Myelofibrosis ### Output: Zilurgisertib;Ruxolitinib